Busted: The Top Healthcare Fraud Schemes of Q2 2025

The second quarter of 2025 has exposed a troubling surge in healthcare fraud, waste, and abuse (FWA) schemes across the United States, with federal and state authorities unraveling elaborate networks designed to exploit public and private insurance systems. From unlicensed clinics billing for phantom services to hospice kickbacks and prescription drug fraud, the tactics employed by poor actors have grown increasingly sophisticated, costing taxpayers and insurers billions of dollars annually. This report examines the most significant healthcare fraud cases uncovered between April and June 2025, shedding light on the evolving strategies used by fraudsters and the coordinated efforts to hold them accountable.

In one of the largest crackdowns of the year, federal prosecutors announced charges against dozens of individuals in Texas and California, alleging schemes that defrauded Medicare, Medicaid, and private insurers of hundreds of millions of dollars. These cases highlight a disturbing trend: fraudsters are no longer operating in isolation but are part of organized networks that span multiple states, leveraging insider knowledge and digital tools to evade detection. As healthcare systems grapple with rising costs and resource constraints, the fight against fraud has become a critical priority for regulators, law enforcement, and industry stakeholders alike.

The Houston Region: A Hotspot for Healthcare Fraud

On April 15, 2025, the U.S. Department of Justice (DOJ) announced charges against 49 individuals in the Houston region as part of a nationwide healthcare fraud enforcement action. The defendants, including physicians, clinic owners, and medical billing specialists, were accused of participating in schemes that resulted in over $1.2 billion in false and fraudulent claims to Medicare, Medicaid, and private insurers. The charges stem from a coordinated effort by the DOJ’s Health Care Fraud Strike Force, which has been targeting high-impact fraud cases since its inception in 2007.

The Houston cases underscore the growing complexity of healthcare fraud. Among the allegations were claims of upcoding—a practice where providers bill for more expensive services than those actually rendered—and phantom billing, where clinics submit claims for services never provided. In one instance, a group of defendants was accused of operating a network of unlicensed clinics that billed Medicare for unnecessary genetic testing, physical therapy, and durable medical equipment. The scheme allegedly involved kickbacks to patient recruiters and the falsification of medical records to justify the claims.

“Healthcare fraud is not a victimless crime,” said U.S. Attorney Alamdar S. Hamdani for the Southern District of Texas in a press release. “It drives up costs for everyone, diverts resources from those who genuinely need care, and undermines the integrity of our healthcare system.” The DOJ’s enforcement action in Houston is part of a broader national effort, with similar cases announced in Florida, Michigan, and New York during the same period.

The Santa Monica Hospice Kickback Scheme: A Case of Insider Deception

In California, a high-profile case emerged in May 2025 involving the CEO of a Santa Monica-based hospice care provider. The DOJ charged the executive with orchestrating a multi-million-dollar kickback scheme that targeted vulnerable patients and their families. According to the indictment, the CEO and co-conspirators paid illegal kickbacks to physicians, marketers, and patient recruiters in exchange for referrals to the hospice. These referrals often involved patients who did not meet the medical criteria for hospice care, which is intended for individuals with a life expectancy of six months or less.

The scheme allegedly resulted in over $200 million in fraudulent claims to Medicare and Medi-Cal (California’s Medicaid program) between 2020 and 2025. Prosecutors described the operation as a “referral mill,” where patients were enrolled in hospice care regardless of their medical needs. In some cases, patients were allegedly kept in hospice for extended periods, even after their conditions improved, to maximize billing. The indictment as well accused the defendants of falsifying medical records to conceal the fraud.

“This case is a stark reminder of how fraudsters exploit some of the most vulnerable members of our society,” said Donald Alway, Assistant Director in Charge of the FBI’s Los Angeles Field Office, in a statement. “Hospice care is a critical service for patients and families facing end-of-life challenges, and schemes like this undermine the trust that is essential to the healthcare system.”

Prescription Drug Fraud: The Rise of Telemedicine Scams

Another alarming trend in Q2 2025 is the proliferation of prescription drug fraud, particularly schemes involving telemedicine platforms. In April, the DOJ unveiled charges against 24 defendants across seven states for their roles in a $1.5 billion fraud scheme that exploited telemedicine to generate false prescriptions for durable medical equipment (DME), such as braces, wheelchairs, and orthotics. The defendants, including telemedicine company executives, physicians, and marketers, allegedly paid illegal kickbacks to telemedicine providers in exchange for fraudulent prescriptions.

The scheme operated as follows: marketers would target Medicare beneficiaries through telemarketing calls, social media ads, and even door-to-door solicitations. The beneficiaries were then connected to telemedicine providers, who would prescribe DME without conducting proper medical evaluations. The prescriptions were subsequently sold to DME suppliers, who billed Medicare for the equipment. In many cases, the beneficiaries never received the equipment or did not need it.

“Telemedicine has the potential to improve access to care, but it also creates new opportunities for fraud,” said Christi A. Grimm, Inspector General of the U.S. Department of Health and Human Services (HHS), in a press release. “Our enforcement actions send a clear message: we will not tolerate schemes that put profits over patients.” The HHS Office of Inspector General (OIG) has been actively monitoring telemedicine fraud and has issued guidance for healthcare providers to ensure compliance with federal regulations.

Unlicensed Clinics and the Shadow Healthcare Economy

Unlicensed clinics have emerged as a significant threat in the healthcare fraud landscape, particularly in states with large immigrant and underserved populations. In June 2025, the Texas Attorney General’s Office announced the shutdown of 12 unlicensed clinics in the Houston and Dallas areas that were allegedly billing Medicaid for services never provided. The clinics, which operated under the guise of providing primary care and specialty services, were found to lack proper licensing, accreditation, and oversight. Investigators discovered that the clinics were submitting claims for services such as diagnostic testing, physical therapy, and even surgeries that were never performed.

The case highlights the challenges faced by regulators in identifying and shutting down unlicensed providers. Many of these clinics operate in low-income neighborhoods, where patients may be less likely to question the legitimacy of the services they receive. The Texas Attorney General’s Office has urged patients to verify the licensing status of healthcare providers through the Texas Medical Board and to report suspicious activity to state authorities.

The Financial and Human Cost of Healthcare Fraud

The financial impact of healthcare fraud is staggering. According to the National Health Care Anti-Fraud Association (NHCAA), healthcare fraud costs the U.S. Tens of billions of dollars annually, with estimates ranging from 3% to 10% of total healthcare expenditures. In 2024 alone, the DOJ recovered over $2.7 billion in settlements and judgments related to healthcare fraud, a figure that underscores the scale of the problem.

Beyond the financial toll, healthcare fraud has profound human consequences. Fraudulent schemes often target vulnerable populations, including the elderly, low-income individuals, and patients with chronic illnesses. In the case of hospice fraud, for example, patients who do not qualify for end-of-life care may be denied access to curative treatments, whereas those who genuinely need hospice services may face delays due to resource constraints. Similarly, prescription drug fraud can lead to unnecessary medical interventions, exposing patients to potential harm from unneeded medications or equipment.

“Healthcare fraud is not just about money—it’s about people’s lives,” said Dr. Shantanu Agrawal, President and CEO of the NHCAA, in an interview. “When fraudsters divert resources from legitimate care, it erodes trust in the healthcare system and puts patients at risk. That’s why collaboration between law enforcement, regulators, and industry stakeholders is so critical.”

How Authorities Are Fighting Back

In response to the growing threat of healthcare fraud, federal and state authorities have ramped up enforcement efforts, leveraging advanced data analytics, artificial intelligence, and interagency collaboration to identify and prosecute fraudulent schemes. The DOJ’s Health Care Fraud Strike Force, which operates in nine cities across the U.S., has been instrumental in targeting high-impact cases. Since its inception, the Strike Force has charged over 4,200 defendants and recovered more than $19 billion in fraudulent proceeds.

One of the key tools in the fight against healthcare fraud is the Centers for Medicare & Medicaid Services (CMS) Fraud Prevention System, which uses predictive analytics to flag suspicious claims before they are paid. The system has saved Medicare over $1.5 billion since its launch in 2011, according to CMS data. The HHS OIG has expanded its exclusion program, which bars individuals and entities convicted of healthcare fraud from participating in federal healthcare programs.

“Technology is a game-changer in the fight against healthcare fraud,” said Deputy Attorney General Lisa Monaco in a speech earlier this year. “By harnessing data and AI, One can identify patterns of fraud more quickly and hold bad actors accountable before they cause further harm.”

What’s Next: Upcoming Enforcement Actions and Policy Changes

As Q2 2025 draws to a close, authorities have signaled that the crackdown on healthcare fraud will continue unabated. The DOJ has indicated that additional charges are expected in the coming months, particularly in cases involving telemedicine fraud, opioid-related schemes, and COVID-19 relief fund abuse. Meanwhile, lawmakers on Capitol Hill are pushing for legislative reforms to strengthen fraud prevention efforts, including proposals to increase funding for the Health Care Fraud Strike Force and expand the use of data analytics in fraud detection.

For patients and healthcare providers, the message is clear: vigilance is key. The HHS OIG has issued consumer alerts to help individuals recognize and report potential fraud, while industry groups such as the American Medical Association (AMA) have published guidance for providers to ensure compliance with federal regulations.

The next major update in the fight against healthcare fraud is expected in September 2025, when the DOJ is scheduled to release its annual report on healthcare fraud enforcement actions. The report will provide a comprehensive overview of the cases prosecuted in 2025, along with insights into emerging fraud trends and enforcement priorities for the year ahead.

Key Takeaways: What You Need to Recognize

• Billions in losses: Healthcare fraud costs the U.S. Tens of billions of dollars annually, with Q2 2025 cases alone exceeding $3 billion in false claims.
• Sophisticated schemes: Fraudsters are increasingly using organized networks, telemedicine platforms, and insider knowledge to evade detection and maximize profits.
• Targeting the vulnerable: Many fraud schemes disproportionately affect the elderly, low-income individuals, and patients with chronic illnesses, putting their health and well-being at risk.
• Enforcement efforts: Federal and state authorities are leveraging data analytics, AI, and interagency collaboration to identify and prosecute fraudulent schemes more effectively.
• Patient and provider responsibility: Verifying the legitimacy of healthcare providers and reporting suspicious activity are critical steps in combating fraud.
• Policy changes on the horizon: Lawmakers are considering legislative reforms to strengthen fraud prevention efforts, including increased funding for enforcement and expanded use of data analytics.

How to Protect Yourself and Report Fraud

If you suspect healthcare fraud, you can report it to the following authorities:

• HHS Office of Inspector General (OIG): Report Fraud Online or call 1-800-HHS-TIPS (1-800-447-8477).
• Centers for Medicare & Medicaid Services (CMS): Report Fraud or call 1-800-MEDICARE (1-800-633-4227).
• State Attorney General’s Office: Contact your state’s Attorney General to report fraud at the state level.
• National Health Care Anti-Fraud Association (NHCAA): Report Fraud.

For healthcare providers, ensuring compliance with federal and state regulations is essential. The AMA and other industry groups offer resources to help providers navigate the complex landscape of healthcare fraud prevention. The HHS OIG provides compliance guidance for healthcare organizations to minimize the risk of fraud and abuse.

As the fight against healthcare fraud continues, staying informed and vigilant is the best defense. Have you encountered a situation that seemed suspicious? Share your experiences in the comments below, and help raise awareness about this critical issue.